SuperworthElevance Health EPS ELV
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jun 30, 2026
- $22.50
- Latest quarter, Q2 FY26
- $6.71
- −13% on a year earlier
- Fiscal year 2025
- $25.12
- −2% on the year before
Elevance Health's earnings per share was $22.50 over the twelve months to Jun 30, 2026, down 4% on a year earlier.
In its latest quarter, Q2 FY26, it was $6.71, down 13% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 7% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $25.12 | −2% |
| FY2024 | $25.61 | +2% |
| FY2023 | $25.17 | +4% |
| FY2022 | $24.25 | −2% |
| FY2021 | $24.72 | +38% |
| FY2020 | $17.91 | −3% |
| FY2019 | $18.44 | +30% |
| FY2018 | $14.20 | −1% |
| FY2017 | $14.36 | +56% |
| FY2016 | $9.21 | −1% |
| FY2015 | $9.33 | +4% |
| FY2014 | $8.98 | +10% |
| FY2013 | $8.18 | +1% |
| FY2012 | $8.13 | +13% |
| FY2011 | $7.19 | +4% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $6.71 | −13% | $22.50 | |
| Q1 FY26 | $8.00 | −17% | $23.51 | |
| Q4 FY25 | $2.47 | +36% | $25.12 | |
| Q3 FY25 | $5.32 | +22% | $24.46 | |
| Q2 FY25 | $7.72 | −22% | $23.50 | |
| Q1 FY25 | $9.61 | +0% | $25.63 | |
| Q4 FY24 | $1.81 | −50% | $25.61 | |
| Q3 FY24 | $4.36 | −20% | $27.43 | |
| Q2 FY24 | $9.85 | +26% | $28.52 | |
| Q1 FY24 | $9.59 | +16% | $26.46 | |
| Q4 FY23 | $3.63 | +1% | $25.17 | |
| Q3 FY23 | $5.45 | −18% | $25.12 |
Against its peers
Companies in Medical - Healthcare Plans nearest Elevance Health's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ELVElevance Health | $22.50 | −4% a year |
| CICigna | $24.17 | +32% a year |
| CVSCVS Health | $3.79 | +6% a year |
| HUMHumana | $10.57 | −19% a year |
| CNCCentene | −$10.44 | −358% a year |
| UNHUnitedHealth | $17.51 | −9% a year |
| OSCROscar Health | $1.39 | |
| Peer median | $7.18 |
Where Elevance Health ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Elevance Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.